Osta Shred (For Her)
Osta Shred (For Her) contains Ostarine and Cardarine. Ostarine allows one to cut down on body fat at a much faster rate, due to it's function of maintaining lean muscle/skeletal tissue. No more worries of losing the lean muscle mass that has taken years to accrue. Cardarine stacked with Ostarine just accelerates the process of fat-loss, with it technically being a PPAR. Cardarine has been reported to enhance overall energy, endurance, and performance. The perfect stack for females (or males) looking to cut down quick.
MK-2866, also known as Ostarine or Enobosarm, is one of the best-studied SARMs. It is a non-steroidal selective androgen receptor modifier that strengthens muscle, bone, and tendons. It does not have the negative side effects associated with testosterone such as raising liver, kidney, and prostate enzymes. Elderly men and women who took modest doses of Ostarine for 12 weeks grew 3 pounds of muscle and lost a pound of fat, with no changes to diet or exercise.
Minor endogenous testosterone suppression. Minor PCT is recommended.
GW-501516 SARMS, also known as Cardarine, is a PPAR agonist that has been shown to have positive effects on muscle building, endurance, increased HDL (good) and decreased LDL (bad) cholesterol, and body recomposition. Cardarine currently has no human studies, but rodent studies have been very encouraging.
When combined with exercise, GW-501516 combined with four weeks of running increased running time by 68%; running distance by 70%; and doubled overall muscular endurance0. Along with exercise GW-501516 increased mitochondrial growth by 50%. Additionally, GW-501516 on its own has been found to activate many of the genes that activate when an organism goes for a run or exercises.
Cardarine is not hormonal so it is not suppressive of endogenous testosterone.
20 – 24 hours.
The most controversial reported side effect is increased cancer incidence. The one animal study that showed this, out of many studies on Cardarine, used a dose one hundred times larger than the normal dose for over 10 times as long as the research chemical is typically used. This “side effect” is highly disputed. More in-depth studies have found that Cardarine actually reduces tumor size.
Additionally, PPAR agonists have in general been found to have anti-cancer activity.